| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/30/2007 | CN1970078A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970077A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1318652C Continuous electrolytic pickling method for metallic products using alternate current supplied cells |
| 05/30/2007 | CN1318596C Vectors based on recombinant defective viral gene group, and their use in formulation of vaccines |
| 05/30/2007 | CN1318590C Human protooncogene KG-20 and protein encoded therein |
| 05/30/2007 | CN1318589C Method for preparing mammal cell kinetin synthetic inhibitory factor |
| 05/30/2007 | CN1318588C Osteoprotegerine |
| 05/30/2007 | CN1318576C Targeted cytolysis of HIV-infected cells by chimerical CD4 receptor bearing cells |
| 05/30/2007 | CN1318450C Modified/chimeric super-antigens and their use |
| 05/30/2007 | CN1318448C Recombined full length human brain red element, preparation method and application thereof |
| 05/30/2007 | CN1318447C Tumor antigen peptides originating in cyclophilin B |
| 05/30/2007 | CN1318446C Transferrin receptor protein of Moraxella |
| 05/30/2007 | CN1318443C Methods for refolding proteins containing free cysteine residues |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/30/2007 | CN1318084C Neuroprotective peptides |
| 05/30/2007 | CN1318023C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/29/2007 | WO2006034832A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 05/29/2007 | US7225083 Determination antagonist, moderators; three-dimensional models |
| 05/29/2007 | US7223905 Plant vitamin E biosynthetic enzymes |
| 05/29/2007 | US7223904 Plant gene sequences II |
| 05/29/2007 | US7223903 Protein kinase stress-related proteins and methods of use in plants |
| 05/29/2007 | US7223901 Soybean FGAM synthase promoters useful in nematode control |
| 05/29/2007 | US7223854 Transfecting or infecting cells and culturing; purified polypeptide, for use in diagnosis |
| 05/29/2007 | US7223853 Secreted frizzled related protein fragments |
| 05/29/2007 | US7223852 Nucleic acids encoding TRAIN-R: a cysteine rich member of the TNF-receptor family |
| 05/29/2007 | US7223850 For use in diagnosis and therapy of disease |
| 05/29/2007 | US7223848 Methods for purifying Fc-containing proteins |
| 05/29/2007 | US7223847 Preparing apoferritin/cobalt protein complex for use in biosensors and bioelectronics |
| 05/29/2007 | US7223846 Urocortin proteins and uses thereof |
| 05/29/2007 | US7223845 Which have one or more sulfated tyrosine residues and a glycan linked to the peptide, the glycan preferably including a sialyl Lewisx group or a sialyl Lewisa group; antiinflammatory, antithrombotic, antimetastatic compounds |
| 05/29/2007 | US7223844 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes |
| 05/29/2007 | US7223840 Antimicrobial peptide |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223838 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/29/2007 | US7223837 Anticancer prodrugs, enhance enzymatic activation rates |
| 05/29/2007 | US7223836 Peptides for chlamydophila pneumoniae vaccine and diagnosis |
| 05/29/2007 | US7223835 Cyclic peptide mimetic for treating cancer; anticarcinogenic agents |
| 05/29/2007 | US7223743 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 05/29/2007 | US7223742 Enhanced solubility of recombinant proteins |
| 05/29/2007 | US7223741 nucleic acids containing unmethylated cytosine-guanine (CpG) dinucleotides activate lymphocytes in a subject and redirect a subject's immune response from a Th2 to a Th1 |
| 05/29/2007 | US7223732 Polypeptides; wound healing agents, antiulcer agents |
| 05/29/2007 | US7223731 Comprises use of thrombospondin biological fragments and domains to treat and prevent cell proliferation disorders; antitumor agents |
| 05/29/2007 | US7223730 Antithrombosis enzyme from the snake venom of agkistrodon acutus |
| 05/29/2007 | US7223729 Suppressing an immune response, CD200, a molecule with previously unknown function belonging to the Ig superfamily, is an immune suppressant; preventing graft rejection, fetal loss, autoimmune diseases, allergies |
| 05/29/2007 | US7223726 Apolipoprotein A-I mutant proteins having cysteine substitutions and polynucleotides encoding same |
| 05/29/2007 | US7223598 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
| 05/29/2007 | US7223597 Anti-apoptosis genes and methods of use thereof |
| 05/29/2007 | US7223594 Immunogens; replication-defective; antibodies; host cells; kits |
| 05/29/2007 | US7223587 Gene conferring lysozyme insensitivity to Corynebacterium |
| 05/29/2007 | US7223586 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth |
| 05/29/2007 | US7223585 Viral purification methods |
| 05/29/2007 | US7223571 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
| 05/29/2007 | US7223566 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors |
| 05/29/2007 | US7223565 for drug screening interleukins; expression in bacteria, yeast, plant, insect, and animal cells; genetic engineering |
| 05/29/2007 | US7223564 Four-helical bundle protein zsig81 |
| 05/29/2007 | US7223563 Nucleic acids; diagnosing and treating hypophosphatemic disorders; diagnosing tumor induced osteomalacia |
| 05/29/2007 | US7223562 Nucleic acid and amino acid sequences of FP-1 protein expressed in follicular papilla of hair follicle; antibodies; transformation, genetic engineering |
| 05/29/2007 | US7223561 Culturing yeast transformed with albumin-encoding nucleotide sequence in a fermentation medium; gene expression, separation, conditioning, adding sodium octanoate; cationic exchange chromatography, elution, ultrafiltration, sterilization, diafiltration, filling vessel |
| 05/29/2007 | US7223558 Fibronectins; drug screening; treating cardiovascular/nervous system disorders |
| 05/29/2007 | US7223557 Polynucleotide encoding a TRP channel family member, TRP-PLIK2 |
| 05/29/2007 | US7223556 Targeted proteolysis by recruitment to ubiquitin protein ligases |
| 05/29/2007 | US7223551 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants |
| 05/29/2007 | US7223550 Biosensor for defecting chemical agents |
| 05/29/2007 | US7223547 for drug screening using genomic expression libraries; solid phase synthesis; kits; genetic engineering |
| 05/29/2007 | US7223542 Diagnosing cancer via determining concentration of marker polypeptides; genetic vaccines; antiproliferative/antitumor agents |
| 05/29/2007 | US7223535 Using epitopic amino acid sequences to detect/diagnose hepatitis A viral infection; immunoassay |
| 05/29/2007 | US7223412 Staphylococcal enterotoxin SEC-SER, expression vector and host cell, production method thereof, and manufacturing method of vaccine |
| 05/29/2007 | US7223411 Administering a mutated herpesvirus having a mutation in genes encoding a protein essential for viral genome replication to render the herpesvirus replication defective; effecting an antibody subclass shift of IgG2a/IgG upon in vivo administration |
| 05/29/2007 | US7223408 Human papillomavirus E6 and E7 polypeptides, mutant polypeptide retains 30% of the immunogenicity of an isolated polypeptide comprising human wild-type papillomavirus E6 and E7 |
| 05/29/2007 | US7223407 Immunogens; water-in-oil emulsions; oil-in-water emulsions; vaccines; freeze drying |
| 05/29/2007 | US7223398 Population of conjugate molecules of an allergen and a polynucleotide comprising an immunostimulatory sequence; polynucleotide conjugated, or attached, to antigens |
| 05/29/2007 | US7223396 Methods of treatment of fistulas in Crohn's disease with anti-TNF antibodies |
| 05/29/2007 | US7223389 Compositions and methods for treatment of cancer |
| 05/29/2007 | CA2389990C Compositions and methods for modulation of plant cell division |
| 05/29/2007 | CA2274853C Multiple branch peptide constructions |
| 05/29/2007 | CA2268758C Immunogenic detoxified mutant e. coli lt-a toxin |
| 05/29/2007 | CA2262476C Viral vectors and their uses |
| 05/24/2007 | WO2007059303A2 Compositions for coordinated vegf and pdgf expression, and methods of use |
| 05/24/2007 | WO2007059298A2 Chimeric immunoreceptor useful in treating human cancers |
| 05/24/2007 | WO2007059242A1 Low-density lipoprotein receptor-related protein 2 clears amyloid-beta peptide a cross the blood-brian barrier via apolipoprotein j |
| 05/24/2007 | WO2007059190A2 Compositions of and methods of using stabilized psma dimers |
| 05/24/2007 | WO2007059000A2 Modulation of angiogenesis by a-beta peptide fragments |
| 05/24/2007 | WO2007058833A2 Dof (dna binding with one finger) sequences and methods of use |
| 05/24/2007 | WO2007058776A2 Hepatocyte growth factor intron fusion proteins |
| 05/24/2007 | WO2007058625A1 Toxin-antitoxin system and applications thereof |
| 05/24/2007 | WO2007058592A1 A method of chromatography using semi-synthetic heparin ligands |
| 05/24/2007 | WO2007058587A1 A compound comprising an autoantigenic peptide and a carrier with a mhc binding motif |
| 05/24/2007 | WO2007058527A2 Inducible expression systems |
| 05/24/2007 | WO2007058360A1 Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivative thereof as active ingredient |
| 05/24/2007 | WO2007058359A1 THERAPEUTIC AGENT FOR SKIN OR SKIN REPAIR-PROMOTING AGENT COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 05/24/2007 | WO2007058267A1 Novel protein and gene encoding the protein |
| 05/24/2007 | WO2007058235A1 Fusion protein and use thereof for pharmaceutical purposes |
| 05/24/2007 | WO2007058105A1 Method for producing pancreas from es cell |
| 05/24/2007 | WO2007057922A1 Targeted fusion proteins for cancer therapy |
| 05/24/2007 | WO2007057778A2 Recombinant polypeptides and methods for detecting and/or quantifying autoantibodies against tsh receptor |
| 05/24/2007 | WO2007057670A1 Nidogen/snep-iike molecule |
| 05/24/2007 | WO2007057665A2 Detection of human platelet antigen (hpa) antibodies |
| 05/24/2007 | WO2007057648A1 Inhibitors of bcl-6 |
| 05/24/2007 | WO2007057444A1 Insl3/rlf polypeptides and uses thereof |